AYTU BioPharma (AYTU)

• Market cap: $27M
• 1 day: 3.92%
• 5 days: 12.29%
• 1 month: 28.64%
• 3 months: 6.43%
• 6 months: 33.84%
• Year to date: 55.88%
• 1 year: 82.76%
• 5 years: -97.86%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Employees: 83